Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells
Open Access
- 6 September 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 120 (10), 2011-2020
- https://doi.org/10.1182/blood-2012-01-402370
Abstract
Dendritic cells (DCs) can capture extracellular antigens and load resultant peptides on to MHC class I molecules, a process termed cross presentation. The mechanisms of cross presentation remain incompletely understood, particularly in primary human DCs. One unknown is the extent to which antigen delivery to distinct endocytic compartments determines cross presentation efficiency, possibly by influencing antigen egress to the cytosol. We addressed the problem directly and quantitatively by comparing the cross presentation of identical antigens conjugated with antibodies against different DC receptors that are targeted to early or late endosomes at distinct efficiencies. In human BDCA1+ and monocyte-derived DCs, CD40 and mannose receptor targeted antibody conjugates to early endosomes, whereas DEC205 targeted antigen primarily to late compartments. Surprisingly, the receptor least efficient at internalization, CD40, was the most efficient at cross presentation. This did not reflect DC activation by CD40, but rather its relatively poor uptake or intra-endosomal degradation compared with mannose receptor or DEC205. Thus, although both early and late endosomes appear to support cross presentation in human DCs, internalization efficiency, especially to late compartments, may be a negative predictor of activity when selecting receptors for vaccine development.Keywords
This publication has 49 references indexed in Scilit:
- Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentationProceedings of the National Academy of Sciences, 2011
- Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9AProceedings of the National Academy of Sciences, 2011
- Designing Vaccines Based on Biology of Human Dendritic Cell SubsetsImmunity, 2010
- The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cellsThe Journal of Experimental Medicine, 2010
- Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cellsThe Journal of Experimental Medicine, 2010
- Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigensThe Journal of Experimental Medicine, 2010
- Mature dendritic cells use endocytic receptors to capture and present antigensProceedings of the National Academy of Sciences, 2010
- Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentationProceedings of the National Academy of Sciences, 2009
- DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypesProceedings of the National Academy of Sciences, 2007
- Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysisThe Journal of Experimental Medicine, 2006